Sara Peggion

Dr. Sara Peggion

Pediatric Surgery, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SPSara Peggion
Sara Peggion
SNSafiullah Najem
Safiullah Najem
JKJan Philipp Kolman
Jan Philipp Kolman
KRKonrad Reinshagen
Konrad Reinshagen
LRLaia Pagerols Raluy
Laia Pagerols Raluy
Neuroblastoma is the most common solid extracranial tumor during childhood; it displays extraordinary heterogeneous clinical courses, from spontaneous regression to poor outcome in high-risk patients due to aggressive growth, metastasizing, and treatment resistance. Therefore, the identification and detailed analysis of promising tumorigenic molecular mechanisms are inevitable. This review highlights the abnormal regulation of NF-κB, Nrf2, and Phox2B as well as their interactions among each other in neuroblastoma. NF-κB and Nrf2 play a key role in antioxidant responses, anti-inflammatory regulation and tumor chemoresistance. Recent studies revealed a regulation of NF-κB by means of the Nrf2/antioxidant response element (ARE) system. On the other hand, Phox2B contributes to the differentiation of immature sympathetic nervous system stem cells: this transcription factor regulates the expression of RET, thereby facilitating cell survival and proliferation. As observed in other tumors, we presume striking interactions between NF-κB, Nrf2, and Phox2B, which might constitute an important crosstalk triangle, whose decompensation may trigger a more aggressive phenotype. Consequently, these transcription factors could be a promising target for novel therapeutic approaches and hence, further investigation on their regulation in neuroblastoma shall be reinforced.

23 February 2026 in JMIR Formative Research
Verified
Journal Article
Open access
NMNariman Mokhaberi
Nariman Mokhaberi
SPSara Peggion
Sara Peggion
SNSafiullah Najem
Safiullah Najem
KRKonrad Reinshagen
Konrad Reinshagen
Background: Digitalization has profoundly transformed health care delivery, including the increasing use of telemedical applications in pediatric care. While the economic benefits and improved access associated with telemedicine in rural regions are well documented, data on caregiver acceptance and demand in metropolitan areas remain limited. Objective: This study aimed to assess caregivers’ willingness to use telemedical tools in the context of pediatric surgery in a metropolitan area. Methods: A 15-item survey was distributed to caregivers of pediatric surgical patients between May and November 2023 at the Department of Pediatric Surgery of the University Medical Center Hamburg-Eppendorf. The survey included questions on sociodemographic factors, previous experience with telemedicine, and preferences regarding telemedical support. Data were analyzed using descriptive statistics. Group comparisons were performed using the χ 2 test or Fisher exact test, where appropriate. Results: A total of 100 families participated in the study. The median age of the pediatric patients was 5 years (IQR 11.75), and the median age of caregivers was 37 years (IQR 14). Congenital conditions accounted for 65% (n=65) of the underlying diagnoses. Overall, 90% (n=88/98) of the interviewed families expressed interest in telemedicine as an integrative health care solution for their children, whereas only 15% (n=15) reported on previous experiences. A primary telemedical consultation was considered acceptable by 53% (n=50/95) of the participants. Caregivers’ preferences were not significantly associated with distance to the nearest hospital ( P =.77), employment status ( P =.89), and family size ( P =.59). Conclusions: Caregivers in an urban pediatric surgical setting show substantial interest in telemedical care options. Acceptance appears to be independent of geographic proximity to health care facilities, suggesting that telemedicine may represent a relevant addition to pediatric surgical care even in metropolitan regions. Further studies are needed to evaluate practical implementation, including technical, legal, and compliance-related aspects.

18 September 2025 in Cells
Verified
Journal Article
Open access
PDF file
SPSara Peggion
Sara Peggion
CVClara Volz
Clara Volz
MTMagdalena Trochimiuk
Magdalena Trochimiuk
IBIsabelle Ariane Bley
Isabelle Ariane Bley
JRJúlia Ramos
Júlia Ramos
LRLaia Pagerols Raluy
Laia Pagerols Raluy
Background: The disialoganglioside GD2, located at the plasma membrane, is selectively overexpressed in various solid tumors, where it contributes to tumor growth and the development of an aggressive tumor phenotype. Thus, over the last two decades GD2 has been gaining importance both as a tumor marker and a therapy target. In neuroblastoma, anti-GD2 monoclonal antibodies and CAR T-cells have become an integral part of the multimodal treatment for relapsed or refractory high-risk cases, which continue to associate with poor prognosis. GD2 characterization in neuroblastoma is well established for bone marrow aspirates and biopsies, but remains challenging in tumoral tissue samples, mostly due to epitope loss upon fixation. Aims: The aim of our work was to assess a new protocol by staining GD2 in tissue specimens prior to fixation. Methods: Positive controls were tissue specimens from patients with histologically confirmed neuroblastoma and GD2 expression in bone marrow aspirate (n = 5). Nephroblastoma or Hodgkin lymphoma samples were considered as negative controls (n = 5). Tissue staining was performed prior to fixation with either anti-GD2 antibody or isotype control, followed by secondary antibody staining and subsequent paraffinization. To examine GD2 staining before and after paraffinization, fluorescence images were acquired using 3D and 2D immunofluorescence microscopy techniques respectively. Results: GD2 signal was detected in all positive controls, while absent in all negative controls. After fixation, paraffinization and slicing no relevant signal loss was observed. Nevertheless, sufficient staining of 3D specimens required long incubation times, which led to increased cytolysis of the unfixed tissue. Conclusions: We were able to establish and validate a novel protocol to reliably perform immunostaining of the membrane antigen GD2 in unfixed, primary neuroblastoma tissue. Although including few limitations, this staining workflow enables relatively quick assessment of GD2 status and thus, might represent a relevant diagnostic tool within the framework of tumor staging and precision medicine.